Search results
Author(s):
Jeffrey J Hsu
,
Ali Nsair
,
Jamil A Aboulhosn
,
et al
Added:
3 years ago
Monomorphic ventricular arrhythmias (MMVA) are not uncommon in athletes,1,2 yet their presence appropriately raises concern among practitioners for possible increased risk of sudden cardiac death (SCD) during sports activity and competition. While all MMVA detected in athletes warrant further evaluation,1 a majority of MMVA in this population are likely to be benign. In some instances of so…
View more
Author(s):
Eyal Nof
,
William G Stevenson
,
Roy John
Added:
3 years ago
Sustained ventricular tachycardia (VT) and ventricular fibrillation (VF) are typically a manifestation of significant structural heart disease and often associated with a high risk of sudden cardiac death. Implantable cardioverter defibrillators (ICDs) remain the mainstay of therapy for prevention of sudden cardiac death associated with these arrhythmias.1 However, ICDs treat the arrhythmia after…
View more
Author(s):
Neil T Srinivasan
,
Richard Schilling
Added:
3 years ago
An estimated 180,000–300,000 sudden cardiac deaths (SCD) occur in the US annually.1,2 Worldwide, sudden and unexpected cardiac death is the most common cause of death,2 accounting for 17 million deaths every year with SCD accounting for 25% of these. The accepted definition of SCD is death that occurs within one hour of onset of symptoms in witnessed cases, and within 24 hours of last being seen…
View more
Author(s):
A John Camm
,
Bernard J Gersh
,
Demosthenes G Katritsis
Added:
3 years ago
Inherited arrhythmias comprise a group of disorders with inherited susceptibility to arrhythmias and conduction disturbances due to mutations in genes mainly encoding the Na+, and K+ channels, and other arrhythmogenic mechanisms such as those linked to Ca++ transport (Table 1).1 The majority of heritable cardiomyopathies and channelopathies are associated with disease-susceptibility genes…
View more
Author(s):
Lauri Holmström
,
Frank Zijun Zhang
,
David Ouyang
,
et al
Added:
10 months ago
Author(s):
Benedict Wiles
,
Anthony C Li
,
Michael C Waight
,
et al
Added:
1 year ago
Author(s):
David Hamon
,
Jane Taleski
,
Marmar Vaseghi
,
et al
Added:
3 years ago
Orthotopic heart transplantation (OHT) is the most effective long-term therapy for end-stage heart disease, with implanted left ventricular assist devices (‘destination therapy’) as an alternative for selected patients. The denervation of the transplanted heart with complete loss of autonomic nervous system modulation, the use of immunosuppressant drugs, as well as the risk of allograft rejection…
View more
Author(s):
Sotiris C Plastiras
,
Haralampos M Moutsopoulos
Added:
2 years ago
Author(s):
Brett Wanamaker
,
Thomas Cascino
,
Vallerie V McLaughlin
,
et al
Added:
3 years ago
Pulmonary hypertension (PH) is a chronic condition that is characterised by elevated pulmonary vascular pressures and can be caused by several disease processes (see Table 1).1 Regardless of the aetiology, PH is a progressive disease with a clinical course characterised by frequent decompensations in advanced stages and often a poor prognosis despite the development of novel therapeutic agents.2…
View more
Author(s):
Takumi Yamada
,
G Neal Kay
Added:
3 years ago
Idiopathic ventricular arrhythmias (IVAs) usually originate from the specific anatomical structures. For the past decade, major IVA origins from both endocardial and epicardial sites have been increasingly recognised (see Table 1).1–3 Catheter ablation of IVAs is usually safe and highly successful, but can sometimes be challenging because of the anatomical obstacles. Therefore, understanding the…
View more